dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine

C120H107Cl2F6N43O2Pt7 — CID 158570171

About dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine

dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine (PubChem CID 158570171) has the molecular formula C120H107Cl2F6N43O2Pt7 and a molecular weight of 3733.91 g/mol. Its IUPAC name is dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine.

Molecular Properties

• Compound Name: dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
• PubChem CID: 158570171
• Molecular Formula: C120H107Cl2F6N43O2Pt7
• Molecular Weight: 3733.91 g/mol
• Exact Mass: 3730.64
• IUPAC Name: dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
• SMILES: CC12CCC(c3c1n[n-]c3-c1nccc3ccccc13)C2(C)C.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(C)[n-]n1.Cc1cc(C)[n-]n1.Cc1n[n-]c(-c2ccccn2)n1.Cc1n[n-]c(-c2ccccn2)n1.Cl[Pt]Cl.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1cc2n(n1)C(n1cccn1)([n+]1ccc[n-]1)[n+]1ccccc1-2.O=C(O)c1ccccn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
• InChI: InChI=1S/C20H20N3.C16H11F3N7.C9H5F3N3.3C9H8N3.4C8H7N4.C6H5NO2.2C5H7N2.2ClH.7Pt/c1-19(2)14-8-10-20(19,3)18-15(14)17(22-23-18)16-13-7-5-4-6-12(13)9-11-21-16;17-15(18,19)14-11-13-12-5-1-2-8-23(12)16(26(13)22-14,24-9-3-6-20-24)25-10-4-7-21-25;10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;3*1-7-6-9(12-11-7)8-4-2-3-5-10-8;2*1-6-4-7(12-11-6)8-5-9-2-3-10-8;2*1-6-10-8(12-11-6)7-4-2-3-5-9-7;8-6(9)5-3-1-2-4-7-5;2*1-4-3-5(2)7-6-4;;;;;;;;;/h4-7,9,11,14H,8,10H2,1-3H3;1-11H;1-5H;3*2-6H,1H3;4*2-5H,1H3;1-4H,(H,8,9);2*3H,1-2H3;2*1H;;;;;;;/q-1;+1;8*-1;;2*-1;;;;6*+2/p-2
• InChIKey: YIXIEDOARQIYPD-UHFFFAOYSA-L
• XLogP: 18.27
• TPSA: 572.15 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 30
• Rotatable Bonds: 12
• Heavy Atoms: 180
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3733.91
LogP ≤ 5	18.27
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	30

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine?

The IUPAC name of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine (CID 158570171) is dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine.

What is the SMILES notation for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine?

The canonical SMILES for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine is CC12CCC(c3c1n[n-]c3-c1nccc3ccccc13)C2(C)C.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2ccccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(-c2cnccn2)[n-]n1.Cc1cc(C)[n-]n1.Cc1cc(C)[n-]n1.Cc1n[n-]c(-c2ccccn2)n1.Cc1n[n-]c(-c2ccccn2)n1.Cl[Pt]Cl.FC(F)(F)c1cc(-c2ccccn2)[n-]n1.FC(F)(F)c1cc2n(n1)C(n1cccn1)([n+]1ccc[n-]1)[n+]1ccccc1-2.O=C(O)c1ccccn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].

What is the InChIKey of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine?

The InChIKey is YIXIEDOARQIYPD-UHFFFAOYSA-L. The full InChI is InChI=1S/C20H20N3.C16H11F3N7.C9H5F3N3.3C9H8N3.4C8H7N4.C6H5NO2.2C5H7N2.2ClH.7Pt/c1-19(2)14-8-10-20(19,3)18-15(14)17(22-23-18)16-13-7-5-4-6-12(13)9-11-21-16;17-15(18,19)14-11-13-12-5-1-2-8-23(12)16(26(13)22-14,24-9-3-6-20-24)25-10-4-7-21-25;10-9(11,12)8-5-7(14-15-8)6-3-1-2-4-13-6;3*1-7-6-9(12-11-7)8-4-2-3-5-10-8;2*1-6-4-7(12-11-6)8-5-9-2-3-10-8;2*1-6-10-8(12-11-6)7-4-2-3-5-9-7;8-6(9)5-3-1-2-4-7-5;2*1-4-3-5(2)7-6-4;;;;;;;;;/h4-7,9,11,14H,8,10H2,1-3H3;1-11H;1-5H;3*2-6H,1H3;4*2-5H,1H3;1-4H,(H,8,9);2*3H,1-2H3;2*1H;;;;;;;/q-1;+1;8*-1;;2*-1;;;;6*+2/p-2.

What are the key properties of dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine?

dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine has a molecular weight of 3733.91 g/mol, XLogP of 18.27, 12 rotatable bonds, 1 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for dichloroplatinum;bis(3,5-dimethylpyrazol-1-ide);5-isoquinolin-1-yl-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridine);bis(2-(5-methylpyrazol-2-id-3-yl)pyrazine);tris(2-(5-methylpyrazol-2-id-3-yl)pyridine);platinum;pentakis(platinum(2+));7-pyrazol-2-ium-1-id-2-yl-7-pyrazol-1-yl-4-(trifluoromethyl)-5,6-diaza-8-azoniatricyclo[6.4.0.02,6]dodeca-1(12),2,4,8,10-pentaene;pyridine-2-carboxylic acid;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine is sourced from PubChem (CID 158570171), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).